Pipeline Analysis

Competitive Intelligence (CI) by understanding the pipeline landscape helps you achieve a sustainable competitive advantage.

GervanoRA Pharma Pipeline analysis provides an in-depth knowledge of all the upcoming competitors in a therapy area. Gaining a thorough understanding of the competitor landscape help you understand the external threats as well as create and sustain the long-term competitive advantage for your firm. It helps you differentiate your product from the competitors. The report covers:

  • Expected new market entrants in a therapy area for upcoming 10 years
  • Expected Product Approval Timeline of all pipeline competitors
  • Expected Product Launch Timeline of all pipeline competitors
  • Expected competitor Launch analysis by geography
  • Pipeline analysis by Mechanism of action, Formulation, Route of administration
  • Pipeline Product analysis by clinical stage of development (Preclinical, Phase I, Phase II, Phase III, Pre-registration, Approved, Launched)
  • Clinical Trial analysis (Ongoing, planned, recently completed, terminated, withdrawn) of all the pipeline molecules
  • An in-depth analysis of all the milestones, deals, mergers, acquisitions, licensing and collaborations for the pipeline assets